Discontinued — last reported Q3 '23
Year-over-year, this metric declined by 83.3%, from $6.00M to $1.00M.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $13.00M | $13.00M | $6.00M | $6.00M | $3.00M | $0.00 | $0.00 | $1.00M |
| QoQ Change | — | +0.0% | -53.8% | +0.0% | -50.0% | -100.0% | — | — |
| YoY Change | — | — | -53.8% | — | — | -100.0% | -100.0% | -83.3% |